Lv11
78 积分 2024-10-09 加入
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
8天前
已完结
Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers for Advanced Chronic Kidney Disease
29天前
已完结
Effectiveness of Empagliflozin vs Dapagliflozin for Kidney Outcomes in Type 2 Diabetes
1个月前
已完结
Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Kidney Outcomes across Baseline Cardiovascular-Kidney-Metabolic Conditions
1个月前
已完结
Another Win for SGLT2 Inhibitors in Chronic Kidney Disease
1个月前
已完结
Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Discontinuation in Patients with CKD
1个月前
已完结
Association between Acute Declines in eGFR during Renin-Angiotensin System Inhibition and Risk of Adverse Outcomes
3个月前
已完结
Long-Term Outcomes of Rituximab-Treated Adult Patients with Podocytopathies
3个月前
已完结
Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis
3个月前
已完结
Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
3个月前
已完结
皖公网安备34019202002308
